Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis

Published:2020-07-08 Issue:4 Volume:52 Page:619-636
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Connelly Margery A.¹^ORCID,Velez Rivera Jonathan²,Guyton John R.²,Siddiqui Mohammad Shadab³,Sanyal Arun J.³^ORCID

Affiliation:

1. Laboratory Corporation of America Holdings (LabCorp); Morrisville NC USA

2. Division of Endocrinology, Metabolism, and Nutrition; Department of Medicine; Duke University Medical Center; Durham NC USA

3. Division of Gastroenterology and Hepatology; Virginia Commonwealth University; Richmond VA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15935/fullpdf

Reference163 articles.

1. Past, present and future perspectives in nonalcoholic fatty liver disease;Sanyal;Nat Rev Gastroenterol Hepatol,2019

2. Non-alcoholic fatty liver disease - a global public health perspective;Younossi;J Hepatol,2019

3. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease;Targher;N Engl J Med,2010

4. Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage;Di Costanzo;Atherosclerosis,2017

5. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis;Vilar-Gomez;Gastroenterology,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive framework for managing metabolic dysfunction-associated steatotic liver disease: analyzing novel risk factors and advances in nanotechnology-based treatments and diagnosis;RSC Medicinal Chemistry;2024

2. Delivery of Oligonucleotide Therapeutics for Macrophage Reprogramming in Inflammatory Diseases;Macrophage Targeted Delivery Systems;2022

3. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice;Hepatology;2021-11-27

4. Statins in Non-alcoholic Steatohepatitis;Frontiers in Cardiovascular Medicine;2021-11-24

5. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment;Diabetes & Metabolism;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3